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Although thiafentanil oxalate has been widely used for wildlife immobili-
sation on different species, no report has been published about its usefulness on 
African buffalo (Syncerus caffer). Thirty-four African buffaloes were successfully 
immobilised at Loskop Dam Nature Reserve, South Africa in July 2013. The ani-
mals were kept in bomas of the nature reserve. The purpose of the immobilisation 
was to provide opportunity for microchip implantation, ear tag placement, in-
tradermal tuberculin test and blood sampling. All animals were immobilised with 
thiafentanil oxalate 6 mg/animal (0.007–0.01 mg/kg) and azaperone 40 mg/animal 
(0.07–0.04 mg/kg) using Dan-inject darts and gun. The opioid reversal agent 
naltrexone hydrochloride 60 mg/animal (0.07–0.1 mg/kg) was given intravenously 
to the ear vein. The mean induction time was 3.9 ± 0.2 min, the recovery time was 
1.65 ± 0.87 min. The results of the present study indicate that thiafentanil oxalate, 
this low-volume, high-potency, reversible drug combined with azaperone pro-
vides fast induction and smooth recovery. The authors recommend this drug com-
bination as a reliable immobilising regimen for African buffalo. 
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Short periods of chemical immobilisation of large wild mammals are often 
required for examination, blood sampling, microchip implantation, application of 
telemetry devices and transportation (Kreeger et al., 2002). 
Thiafentanil oxalate is a potent μ receptor agonist opioid drug. It is 6,000 
times more potent than morphine (West et al., 2008). Its potency is similar to that 
of etorphine hydrochloride, but its induction time and duration of effect are 
shorter (West et al., 2008). The potency and concentrated formulation of thiafen-
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tanil oxalate (usually 10 mg/ml) make it very useful for remote delivery, but 
these factors increase the chance of accidental human intoxication (West et al., 
2008). The effect of thiafentanil can be reversed with naltrexone (West et al., 
2008). 
Naltrexone is a competitive, pure opioid receptor antagonist at μ and κ re-
ceptors, and to a lesser extent at δ receptors (Plumb, 2011; Taylor et al., 2013). 
In human medicine it is used in the management of opioid and alcohol depend-
ence (Taylor et al., 2013). In veterinary medicine it is the antidote of choice for 
etorphine, carfentanil and thiafentanil. The advantage of naltrexone over 
naloxone is that it has a longer metabolic half-life, and thus renarcotisation is 
rarely a problem when naltrexone is used (Kreeger et al., 2002). 
Azaperone is a neuroleptic sedative drug belonging to the butyrophenone 
class. It acts mainly as a dopamine antagonist but also has some antihistaminic 
and anticholinergic properties (Plumb, 2011). It is a common tranquiliser of 
choice in most anaesthetic drug combinations in wildlife medicine (Kreeger et 
al., 2002). It causes sedation and vasodilatation, decreases the heart rate, and can 
reduce the side effects of opioids by increasing the respiratory rate and suppress-
ing vomiting (Wolfe et al., 2008). Interestingly, it can cause aggression in oryx 
(Kreeger et al., 2002). 
Thiafentanil has been widely used for wildlife immobilisation on different 
species: nyala (Cooper et al., 2005), Lichtenstein’s hartebeest (Citino et al., 2002), 
mule deer (Wolfe et al., 2004), emu (Cushing and McClean, 2010), Tibetan yak 
(Cushing et al., 2011), gaur (Napier et al., 2011), axis deer (Smith et al., 2006) 
and greater rhea (Ter Beest et al., 2012). The thiafentanil–azaperone combination 
for African buffalo (Syncerus caffer) immobilisation has been mentioned in 
books (Kreeger et al., 2002; West et al., 2008). The authors, however, could not 
find any peer-reviewed journal article about its usefulness on this species. 
Thirty-four African buffaloes were successfully anaesthetised at Loskop 
Dam Nature Reserve, Mpumalanga, South Africa (S: 25°24', E: 29°21') on 23 
July 2013. These animals belong to the largest subspecies of the African buffalo, 
the Cape buffalo (Syncerus caffer caffer). The animals were captured in the na-
ture reserve and transported to bomas (boma is a South-African term to describe 
a fortified livestock enclosure or stockade) on the reserve, where they were 
housed in five groups of six to 11 animals, corresponding to the different herds 
from which they were captured. 
The purpose of immobilisation in the boma was to provide opportunity for 
microchip implantation, morphometric measurements, photography, ear tag 
placement, intradermal tuberculin test and for blood sampling for foot and mouth 
disease, brucellosis (Brucella abortus) and corridor disease (Theileria parva) di-
agnosis. The estimated body weights of the animals were 600–900 kg. Due to 
health and safety reasons, all animals within a boma were immobilised at the 
same time. The procedure took place in the early morning. The food was with-
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held for 24 h and water for 12 h to prevent regurgitation of the rumen contents 
and the development of rumen tympany as a result of the immobilisation. 
Each buffalo was immobilised with thiafentanil oxalate (A3080, 10 mg/ml 
Wildlife Pharmaceuticals, White River, Mpumalanga, South Africa) at a dose of 
6 mg/animal (0.007–0.01 mg/kg) and azaperone (Stresnil, 40 mg/ml, Schering-
Plough Animal Health, Kenilworth, New Jersey, USA) at a dose of 40 mg/ 
animal (0.07–0.04 mg/kg) intramuscularly, using Dan-inject darts and gun (Dan 
Inject ApS, Børkop, Denmark). 
After immobilisation, the animals were moved to sternal recumbency and 
their eyes were covered using blindfolds to decrease external visual stimulation 
and calm the animals (Mitchell et al., 2004; West et al., 2008). 
Blood samples were taken from the jugular vein as soon as practical after 
immobilisation. Induction time was recorded as the time from darting until ster-
nal or lateral recumbency was attained, and recovery time was the interval from 
receiving the reversal agent until the animal was able to maintain a standing pos-
ture. Palpebral and corneal reflexes, muscle tones as well as heart and respiratory 
rates were routinely monitored during the immobilisation, but only the respira-
tory rate was recorded in the case of 10 animals. Unfortunately, due to the num-
ber of animals immobilised at the same time, detailed monitoring using a pulse 
oximeter, ECG device capnograph or blood pressure meter was not possible. 
The reversal agent naltrexone hydrochloride (Trexonil 50 mg/ml, Wildlife 
Laboratories, Fort Collins, Colorado, USA) was given intravenously into the ear 
vein at a dose of 60 mg/animal (0.07–0.1 mg/kg) after all the procedures on all 
the animals within a boma had been completed. The handling time, taken as the 
time between when the last animal within a boma reached recumbency and the 
time when the reversal agent was administered, was 17–25 min. For safety rea-
sons, all animals within a boma were reversed at the same time and the veteri-
nary staff left the enclosure immediately. 
To compare the induction and recovery times of male and female buffalos, 
resampling approximation of the t-test was performed using Resampling Stats 
Add-in for Excel (Statistics.com, Arlington, USA) and Microsoft Excel (Micro-
soft, Washington, U.S.) software. 
The mean induction time of the buffaloes (n = 34; 11 males and 23 fe-
males) was 3.9 ± 0.2 min (range: 3.5–4 min) and the recovery time was 1.65 ± 
0.87 min (range: 1–4 min). The induction and recovery times of female and male 
buffalos were not significantly different (P > 0.05). 
The respiratory rate was recorded in the case of 10 animals. The mean res-
piratory rate was 29.4 ± 8.81/min (range: 14–48/min). 
Regardless of the fasting before the immobilisation, one female buffalo 
regurgitated a small amount of fluid during the procedure. The oral cavity of the 
animal was immediately cleaned to prevent aspiration of the rumen content. 
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Apart from this, no adverse, short-term effects were detected after drug admini-
stration. 
Our results suggest that thiafentanil immobilisation of African buffaloes in 
bomas is safe and effective. The immobilisation period was sufficient for blood 
sampling, morphometric measurements, photography, microchip implantation 
and ear tag placement. Unfortunately, due to the high number of animals immo-
bilised at the same time, detailed monitoring (e.g. pulse oximetry, repeated blood 
sampling, recording heart rate and respiratory rate) was not possible. 
The results of the present study indicate that thiafentanil oxalate, this low-
volume, high-potency, reversible drug combined with azaperone provides fast 
induction and smooth recovery. The authors recommend this drug combination 
as a reliable immobilising regimen for African buffaloes. 
 
 
Acknowledgements 
For their excellent work, we thank the veterinary interns Laura Pittenger and 
Tony Hall, the Conservation Medicine students and lecturers of Murdoch University: 
Linda-Jane Bowden, Rebekah Bruce, Petra Connell, Di Crispe, Ashton Hollwarth, Marek 
Misiewicz, Caroline Mynott, Emily Swan, Rachel Tidman, Tymon Yeo, Jordan Zec, Bec 
Donaldson, Lian Yeap, Scott McEwing and Kris Warren, and the team of the Loskop 
Dam Nature Reserve and the Mpumalanga Parks Board.  
 
 
References 
Citino, S. B., Bush, M., Grobler, D. and Lance, W. (2002): Anesthesia of boma-captured Lichten-
stein’s hartebeest (Sigmoceros lichtensteinii) with a combination of thiafentanil, mede-
tomidine, and ketamine. J. Wildl. Dis. 38, 457–462. 
Cooper, D. V., Grobler, D., Bush, M., Jessup, D. and Lance, W. (2005): Anaesthesia of nyala 
(Tragelaphus angasi) with a combination of thiafentanil (A3080), medetomidine and 
ketamine. J. S. Afr. Vet. Assoc. 76, 18–21. 
Cushing, A. and McClean, M. (2010): Use of thiafentanil–medetomidine for the induction of anes-
thesia in emus (Dromaius novaehollandiae) within a wild animal park. J. Zoo Wildl. Med. 
41, 234–241. 
Cushing, A., McClean, M., Stanford, M., Lohe, T., Alcantar, B. E. and Chirife, A. D. (2011): An-
esthesia of Tibetan yak (Bos grunniens) using thiafentanil–xylazine and carfentanil–
xylazine. J. Zoo Wildl. Med. 42, 713–717. 
Kreeger, T. J., Arnemo, J. M. and Raath, J. P. (2002): Handbook of Wildlife Chemical Immobiliza-
tion: International Edition. Wildlife Pharmaceuticals, White River, Mpumalanga, South 
Africa. 
Mitchell, K. D., Stookey, J. M., Laturnas, D. K., Watts, J. M., Haley, D. B. and Huyde, T. (2004): 
The effects of blindfolding on behavior and heart rate in beef cattle during restraint. Appl. 
Anim. Behav. Sci. 85, 233–245. 
Napier, J. E., Loskutoff, N. M., Simmons, L. G. and Armstrong, D. L. (2011): Comparison of car-
fentanil–xylazine and thiafentanil–medetomidine in electroejaculation of captive gaur (Bos 
gaurus). J. Zoo Wildl. Med. 42, 430–436. 
 THIAFENTANIL OXALATE AND AZAPERONE FOR IMMOBILISATION OF AFRICAN BUFFALO 15 
Acta Veterinaria Hungarica 63, 2015 
Plumb, D. C. (2011): Plumb’s Veterinary Drug Handbook. Seventh edition. PharmaVet, Stock-
holm, Wis. 
Smith, K. M., Powell, D. M., James, S. B., Calle, P. P., Moore, R. P., Zurawka, H. S., Goscilo, S. 
and Raphael, B. L. (2006): Anesthesia of male axis deer (Axis axis): evaluation of thiafen-
tanil, medetomidine, and ketamine versus medetomidine and ketamine. J. Zoo Wildl. Med. 
37, 513–517. 
Taylor, R. Jr., Pergolizzi, J. V. Jr., Porreca, F. and Raffa, R. B. (2013): Opioid antagonists for pain. 
Expert Opin. Investig. Drugs 22, 517–525. 
Ter Beest, J., McClean, M., Cushing, A. and Bildfell, R. (2012): Thiafentanil-dexmedetomidine-
telazol anesthesia in greater rheas (Rhea americana). J. Zoo Wildl. Med. 43, 802–807. 
West, G., Heard, D. and Caulkett, N. (2008): Zoo Animal and Wildlife Immobilization and Anes-
thesia. John Wiley & Sons, Hoboken, NJ. 
Wolfe, L. L., Goshorn, C. T. and Baruch-Mordo, S. (2008): Immobilization of black bears (Ursus 
americanus) with a combination of butorphanol, azaperone, and medetomidine. J. Wildl. 
Dis. 44, 748–752. 
Wolfe, L. L., Lance, W. R. and Miller, M. W. (2004): Immobilization of mule deer with thiafen-
tanil (A-3080) or thiafentanil plus xylazine. J. Wildl. Dis. 40, 282–287. 
